ROBERT J. MORE - 29 May 2025 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Director
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
29 May 2025
Transactions value $
$0
Form type
4
Filing time
02 Jun 2025, 16:05:08 UTC
Previous filing
03 Jun 2024
Next filing
02 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MORE ROBERT J Director C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD /s/ Ali D. Fawaz, Attorney-in-Fact 02 Jun 2025 0001207792

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Award $0 +22.2K $0.00 22.2K 29 May 2025 Common Stock 22.2K $9.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 29, 2025, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date.